BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 29986618)

  • 1. Disease Progression in a Patient With Indolent T-Cell Lymphoproliferative Disease of the Gastrointestinal Tract.
    Perry AM; Bailey NG; Bonnett M; Jaffe ES; Chan WC
    Int J Surg Pathol; 2019 Feb; 27(1):102-107. PubMed ID: 29986618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Indolent T-Cell/Natural Killer-Cell Lymphomas/Lymphoproliferative Disorders of the Gastrointestinal Tract-What Have We Learned in the Last Decade?
    Wang XG; Yin WH; Wang HY
    Lab Invest; 2024 Apr; 104(4):102028. PubMed ID: 38382808
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An unusual case report of indolent T-cell lymphoproliferative disorder with aberrant CD20 expression involving the gastrointestinal tract and bone marrow.
    Wang X; Ng CS; Chen C; Yu G; Yin W
    Diagn Pathol; 2018 Oct; 13(1):82. PubMed ID: 30342536
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indolent T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: a review and update.
    Matnani R; Ganapathi KA; Lewis SK; Green PH; Alobeid B; Bhagat G
    Hematol Oncol; 2017 Mar; 35(1):3-16. PubMed ID: 27353398
    [TBL] [Abstract][Full Text] [Related]  

  • 5. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
    van Vliet C; Spagnolo DV
    Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indolent T-cell lymphoproliferative disorder of gastrointestinal tract with unusual clinical courses: report of 6 cases and literature review.
    Fan W; Niu L; He H; Yuan J; Yuan F; Shi X; Wang Y; Chen M; Huang M; Zhou F; Xu J; Chen Q
    Virchows Arch; 2023 Apr; 482(4):729-743. PubMed ID: 36472661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastrointestinal T- and NK-cell lymphomas and indolent lymphoproliferative disorders.
    Soderquist CR; Bhagat G
    Semin Diagn Pathol; 2020 Jan; 37(1):11-23. PubMed ID: 31522873
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Indolent T-cell lymphoproliferative disease of the gastrointestinal tract.
    Perry AM; Warnke RA; Hu Q; Gaulard P; Copie-Bergman C; Alkan S; Wang HY; Cheng JX; Bacon CM; Delabie J; Ranheim E; Kucuk C; Hu X; Weisenburger DD; Jaffe ES; Chan WC
    Blood; 2013 Nov; 122(22):3599-606. PubMed ID: 24009234
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indolent T-Cell Lymphoproliferative Disease of the GI Tract: Insights for Better Diagnosis, Prognosis, and Appropriate Therapy.
    Küçük C; Wei L; You H
    Front Oncol; 2020; 10():1276. PubMed ID: 32850389
    [TBL] [Abstract][Full Text] [Related]  

  • 10. T-cell LPD of the GIT: first do no harm.
    Said J
    Blood; 2013 Nov; 122(22):3548-50. PubMed ID: 24263952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Feline low-grade intestinal T cell lymphoma: a unique natural model of human indolent T cell lymphoproliferative disorder of the gastrointestinal tract.
    Freiche V; Cordonnier N; Paulin MV; Huet H; Turba ME; Macintyre E; Malamut G; Cerf-Bensussan N; Molina TJ; Hermine O; Bruneau J; Couronné L
    Lab Invest; 2021 Jun; 101(6):794-804. PubMed ID: 33692440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Indolent T-cell lymphoproliferative disorder of the gastrointestinal tract: a tricky diagnosis of a gastric case.
    Zanelli M; Zizzo M; Sanguedolce F; Martino G; Soriano A; Ricci S; Castro Ruiz C; Annessi V; Ascani S
    BMC Gastroenterol; 2020 Oct; 20(1):336. PubMed ID: 33054767
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Peripheral T-cell lymphoma with gastrointestinal involvement and indolent T-lymphoproliferative disorders of the gastrointestinal tract.
    Kohri M; Tsukasaki K; Akuzawa Y; Tanae K; Takahashi N; Saeki T; Okamura D; Ishikawa M; Maeda T; Kawai N; Matsuda A; Arai E; Arai S; Asou N
    Leuk Res; 2020 Apr; 91():106336. PubMed ID: 32151888
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Update on lymphoproliferative disorders of the gastrointestinal tract: disease spectrum from indolent lymphoproliferations to aggressive lymphomas.
    Montes-Moreno S; King RL; Oschlies I; Ponzoni M; Goodlad JR; Dotlic S; Traverse-Glehen A; Ott G; Ferry JA; Calaminici M
    Virchows Arch; 2020 May; 476(5):667-681. PubMed ID: 31773249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Indolent T-cell lymphoproliferative disease with synchronous diffuse large B-cell lymphoma: A case report.
    Guo L; Wen Z; Su X; Xiao S; Wang Y
    Medicine (Baltimore); 2019 Apr; 98(17):e15323. PubMed ID: 31027102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An aggressive extranodal NK-cell lymphoma arising from indolent NK-cell lymphoproliferative disorder.
    Huang Q; Chang KL; Gaal KK; Weiss LM
    Am J Surg Pathol; 2005 Nov; 29(11):1540-3. PubMed ID: 16224224
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinicopathological categorization of hydroa vacciniforme-like lymphoproliferative disorder: an analysis of prognostic implications and treatment based on 19 cases.
    Guo N; Chen Y; Wang Y; Huang Y; Feng Y; Li M; Rao H
    Diagn Pathol; 2019 Jul; 14(1):82. PubMed ID: 31315684
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Indolent NK-Cell Lymphoproliferative Disorder of the Gastrointestinal Tract - a Report of two Cases of a new Provisional Entity on the World Health Organization Classification of Hematolymphoid Tumors.
    Alves de Castro JV; Costa FD; Ferreira CR
    Int J Surg Pathol; 2023 Aug; 31(5):596-599. PubMed ID: 35903908
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A unique case of an indolent CD56-positive T-cell lymphoproliferative disorder of the gastrointestinal tract: a lesion potentially misdiagnosed as natural killer/T-cell lymphoma.
    McElroy MK; Read WL; Harmon GS; Weidner N
    Ann Diagn Pathol; 2011 Oct; 15(5):370-5. PubMed ID: 20952278
    [TBL] [Abstract][Full Text] [Related]  

  • 20. VITREORETINAL INVOLVEMENT BY INDOLENT T-CELL LYMPHOPROLIFERATIVE DISORDER OF THE GASTROINTESTINAL TRACT DIAGNOSED BY FLUORESCENCE IN SITU HYBRIDIZATION.
    Salman AR; Ferenchak K; Olsen TW; Smith WM; Ketterling RP; McPhail ED; Salomao DR; Dalvin LA
    Retin Cases Brief Rep; 2023 Sep; 17(5):572-576. PubMed ID: 37490925
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.